Results

Total Results: 1,175 records

Showing results for "fentanyl".

81. FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. | PSNet
    psnet.ahrq.gov/issue/fda-recommends-health-care-professionals-discuss-naloxone-all-patients-when-prescribing
    October 09, 2013 - Related Resources From the Same Author(s) FDA requiring color changes to Duragesic … (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause … January 9, 2005 Fentanyl transdermal system (marketed as Duragesic) information. … October 3, 2022 Accidental exposures to fentanyl patches continue to be deadly to children … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

82. FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. | PSNet
    psnet.ahrq.gov/issue/fda-requires-label-warnings-prohibit-sharing-multi-dose-diabetes-pen-devices-among-patients
    March 04, 2015 - January 19, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … December 10, 2008 Fentanyl transdermal system (marketed as Duragesic) information. … October 3, 2022 Accidental exposures to fentanyl patches continue to be deadly to children … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

83. Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. | PSNet
    psnet.ahrq.gov/issue/apotex-corp-issues-voluntary-nationwide-recall-enoxaparin-sodium-injection-usp-due
    February 16, 2011 - January 19, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … March 4, 2015 Accidental exposures to fentanyl patches continue to be deadly to children … July 21, 2021 Fentanyl transdermal system (marketed as Duragesic) information. … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

84. Bar Code Label Requirements for Blood and Blood Components. | PSNet
    psnet.ahrq.gov/issue/bar-code-label-requirements-blood-and-blood-components
    May 03, 2006 - November 13, 2013 FDA requiring color changes to Duragesic (fentanyl) pain patches to … February 20, 2013 Accidental exposures to fentanyl patches continue to be deadly to children … September 29, 2021 Accidental exposures to fentanyl patches continue to be deadly to … March 13, 2016 Fentanyl transdermal system (marketed as Duragesic) information.

85. Important change to heparin container labels to clearly state the total drug strength. | PSNet
    psnet.ahrq.gov/issue/important-change-heparin-container-labels-clearly-state-total-drug-strength
    May 30, 2012 - January 19, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … February 24, 2022 - February 24, 2022 Fentanyl transdermal system (marketed as Duragesic … October 3, 2022 Accidental exposures to fentanyl patches continue to be deadly to children … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

86. Making Medical Devices Safer at Home. | PSNet
    psnet.ahrq.gov/issue/making-medical-devices-safer-home
    July 31, 2013 - January 19, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … March 3, 2010 Accidental exposures to fentanyl patches continue to be deadly to children … December 10, 2008 Fentanyl transdermal system (marketed as Duragesic) information. … September 1, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

87. Safety Problems With Your Child's Medical Device? | PSNet
    psnet.ahrq.gov/issue/safety-problems-your-childs-medical-device
    January 09, 2013 - March 26, 2008 FDA requiring color changes to Duragesic (fentanyl) pain patches to aid … August 5, 2015 Fentanyl transdermal system (marketed as Duragesic) information. … March 3, 2010 Accidental exposures to fentanyl patches continue to be deadly to children … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

88. Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays. | PSNet
    psnet.ahrq.gov/issue/serious-adverse-events-accidental-ingestion-children-over-counter-eye-drops-and-nasal-sprays
    December 19, 2012 - January 19, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … April 30, 2014 Fentanyl transdermal system (marketed as Duragesic) information. … October 3, 2022 Accidental exposures to fentanyl patches continue to be deadly to children … August 11, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

89. Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume. | PSNet
    psnet.ahrq.gov/issue/hospira-carpuject-pre-filled-cartridges-drug-alert-products-may-contain-more-intended-fill
    December 19, 2012 - August 5, 2020 FDA requiring color changes to Duragesic (fentanyl) pain patches to aid … May 25, 2022 Fentanyl transdermal system (marketed as Duragesic) information. … October 3, 2022 Accidental exposures to fentanyl patches continue to be deadly to children … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

90. Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning. | PSNet
    psnet.ahrq.gov/issue/design-endoscopic-retrograde-cholangiopancreatography-ercp-duodenoscopes-may-impede-effective
    March 11, 2015 - August 5, 2020 FDA requiring color changes to Duragesic (fentanyl) pain patches to aid … March 8, 2023 Fentanyl transdermal system (marketed as Duragesic) information. … October 3, 2022 Accidental exposures to fentanyl patches continue to be deadly to children … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

91. FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. | PSNet
    psnet.ahrq.gov/issue/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and
    January 25, 2017 - February 16, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … March 4, 2015 Fentanyl transdermal system (marketed as Duragesic) information. … October 3, 2022 Accidental exposures to fentanyl patches continue to be deadly to children … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

92. Computerized Prescriber Order Entry Medication Safety (CPOEMS): Uncovering and Learning From Issues and Errors. | PSNet
    psnet.ahrq.gov/issue/computerized-prescriber-order-entry-medication-safety-cpoems-uncovering-and-learning-issues
    February 05, 2014 - January 19, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … July 11, 2023 Fentanyl transdermal system (marketed as Duragesic) information. … March 3, 2010 Accidental exposures to fentanyl patches continue to be deadly to children … October 6, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

93. FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. | PSNet
    psnet.ahrq.gov/issue/fda-alerts-patients-and-health-care-professionals-epipen-auto-injector-errors-related-device
    December 16, 2020 - January 19, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … January 25, 2023 Fentanyl transdermal system (marketed as Duragesic) information. … October 3, 2022 Accidental exposures to fentanyl patches continue to be deadly to children … August 20, 2021 Accidental exposures to fentanyl patches continue to be deadly to children

94. RESEARCH FINDINGS #49: Pre-COVID-19 Retail Use and Expenditures for Drugs That Were Subsequently Used to Treat COVID-19
    meps.ahrq.gov/data_files/publications/rf49/rf49.shtml
    July 01, 2021 - Among the COVID-19-relevant drugs in our study, fentanyl (a synthetic opioid) and warfarin (a coagulation … About half of fentanyl fills were prescribed for osteoarthritis and other non-traumatic joint disorders … Fentanyl and warfarin (an anticoagulant) had the highest average annual fills per user at 6.0 and 5.7 … Fentanyl use was higher among women, while the percentage using warfarin was higher among men. … Both had strong gradients by health status with use of fentanyl ranging from 0.004 percent for those

95. Pre-COVID-19 Retail Use and Expenditures for Drugs That Were Subsequently Used to Treat COVID-19 (pdf file)
    meps.ahrq.gov/data_files/publications/rf49/rf49.pdf
    December 04, 2020 - • Among the COVID-19-relevant drugs in our study, fentanyl (a synthetic opioid) and warfarin (a … Fentanyl and warfarin (an anticoagulant) had the highest average annual fills per user at 6.0 and 5.7 … For fentanyl (table 2A) and warfarin (table 2B), the two drugs with the highest number of fills per … Fentanyl use was higher among women, while the percentage using warfarin was higher among men. … About half of fentanyl fills were prescribed for either osteoarthritis and other non- traumatic joint

96. About AHRQ's Work on Opioids and Substance Use Disorders | Agency for Healthcare Research and Quality
    www.ahrq.gov/opioids/about.html
    August 01, 2021 - deaths was initially driven by misuse of prescription opioids but is now also fueled by rising use of fentanyl

97. Adverse and Temporary Harm Events in Long-Term-Care Hospitals (LTCH) Designated in Office of Inspector General Report1 as Clearly Preventable or Likely Preventable, by Clinical Category (pdf file)
    pso.ahrq.gov/sites/default/files/wysiwyg/oig-list-long-term-care-hospitals-2019.pdf
    January 01, 2019 - ultimately death • Altered mental status and respiratory failure secondary to opioids (hydromorphone and fentanyl … Cascade with oversedation and hypotension while on multiple opioids (oxycodone/ acetaminophen and fentanyl … ) • Hallucinations and agitation while on opioid analgesic medication (fentanyl and meperidine) • Insomnia … Lethargy while on multiple psychotropic medications (quetiapine, lorazepam, alprazolam) and opioid (fentanyl … ) • Lethargy while on opioid given for pain (fentanyl) • Oversedation due to opioid analgesic (hydrocodone

98. Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/studies/index.html?page=83
    January 01, 2024 - This study examined the associations between fentanyl use and initiation, persistence, and retention … Exposure to fentanyl use was measured by urine drug screening. … Baseline fentanyl use was 64% for participants. … for fentanyl, but there was no evidence that fentanyl use impacted the likelihood of TAU initiation. … Associations between fentanyl use and initiation, persistence, and retention on medications for opioid

99. FDA Safety Communication: recommendations to reduce surgical fires and related patient injury. | PSNet
    psnet.ahrq.gov/issue/fda-safety-communication-recommendations-reduce-surgical-fires-and-related-patient-injury
    October 19, 2022 - January 19, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … May 25, 2022 Fentanyl transdermal system (marketed as Duragesic) information. … October 3, 2022 Accidental exposures to fentanyl patches continue to be deadly to children

100. Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health. | PSNet
     psnet.ahrq.gov/issue/medical-device-safety-action-plan-protecting-patients-promoting-public-health
     November 28, 2018 - January 19, 2011 FDA requiring color changes to Duragesic (fentanyl) pain patches to … March 3, 2010 Accidental exposures to fentanyl patches continue to be deadly to children … December 10, 2008 Fentanyl transdermal system (marketed as Duragesic) information.